However, this leaves the difficulty to decide on a cutoff value, i.e., for the average methylation of a limited number of CpGs in the MGMT promoter that should ideally reflect on the MGMT activity in the tumor, which is until now rather difficult to obtain. This evidence concerns the gene MGMT and neoplasm.